BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 120 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $13,163,000 | +52.6% | 2,079,497 | +6.3% | 0.00% | +100.0% |
| Q3 2016 | $8,628,000 | +63.9% | 1,956,570 | +5.5% | 0.00% | 0.0% |
| Q2 2016 | $5,265,000 | -0.4% | 1,854,035 | -0.8% | 0.00% | 0.0% |
| Q1 2016 | $5,287,000 | -71.6% | 1,868,245 | +3.5% | 0.00% | -66.7% |
| Q4 2015 | $18,631,000 | -3.4% | 1,805,315 | +6.7% | 0.00% | 0.0% |
| Q3 2015 | $19,292,000 | -29.2% | 1,692,262 | -7.2% | 0.00% | -25.0% |
| Q2 2015 | $27,232,000 | +57.6% | 1,823,953 | -4.7% | 0.00% | +33.3% |
| Q1 2015 | $17,277,000 | -25.7% | 1,913,277 | +0.0% | 0.00% | -25.0% |
| Q4 2014 | $23,260,000 | +23.1% | 1,912,804 | -1.0% | 0.00% | +33.3% |
| Q3 2014 | $18,899,000 | -23.8% | 1,932,365 | -0.6% | 0.00% | -25.0% |
| Q2 2014 | $24,797,000 | +117.1% | 1,944,841 | +80.2% | 0.00% | +100.0% |
| Q1 2014 | $11,420,000 | +32.8% | 1,079,396 | -4.6% | 0.00% | 0.0% |
| Q4 2013 | $8,601,000 | +1.4% | 1,131,652 | -2.9% | 0.00% | 0.0% |
| Q3 2013 | $8,483,000 | +373.9% | 1,165,193 | +0.9% | 0.00% | – |
| Q2 2013 | $1,790,000 | – | 1,154,701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |